Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
SPAC HighCape Capital Acquisition Corp. (CAPAU) Surges on Merger with Quantum-Si
-
View Smart Windows Transform St. John’s Terminal, Oxford Properties’ Flagship US Development in New York City
-
Quantum-Si, a Pioneer in Semiconductor Chip-Based Proteomics, to Combine with HighCape Capital Acquisition Corp.
-
NexImmune Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Corvus Pharmaceuticals Announces Closing of Public Offering of Common Stock
-
Sanara MedTech Inc. Announces Closing of $31.6 Million Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
-
Aleafia Health Announces Increase to Bought Deal Offering of Units to $20 Million
-
Outlook Therapeutics to Participate in Cantor Fitzgerald’s Virtual Panel Discussion: Eyeing Key Events and Programs in the Ophthalmology Space in 2021
-
AEye To Go Public Through Merger With CF Finance Acquisition Corp. III (CFAC)
-
AEye, Global Leader In Active, High-Performance LiDAR Solutions, To Go Public Through Merger With CF Finance Acquisition Corp. III
-
Companies with NDRs 2/17
-
CF Finance Acquisition Corp. II Announces Registration Statement Effectiveness and Special Meeting Date to Approve Business Combination with View, Inc.
-
Form 424B3 Cantor Fitzgerald Income
-
Kadmon Announces Closing of $240 Million Convertible Senior Notes Offering Including Full Exercise of $40 Million Over-Allotment Option
-
TherapeuticsMD Announces Closing of its Underwritten Public Offering of Common Stock
-
KalVista Pharmaceuticals Announces the Closing of its Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Dune Acquisition Corporation Announces the Separate Trading of its Common Stock and Warrants, Commencing February 19, 2021
-
Dune Acquisition Corporation Announces the Separate Trading of its Common Stock and Warrants, Commencing February 19, 2021
-
Cantor Fitzgerald Starts Canada Nickel Company Inc (CNC:CN) (CNIKF) at Spec. Buy
-
Aphria Inc. (APHA:CN) (APHA) PT Raised to Cdn$32.50 at Cantor Fitzgerald
-
Galmed Pharma (GLMD) Announces Pricing of $10 Million Public Offering of Ordinary Shares
-
Galmed Pharmaceuticals Announces Pricing of $10 Million Public Offering of Ordinary Shares
-
Grayscale Investments® Expands Leadership Team with C-Suite Hires
-
Grayscale Investments® Expands Leadership Team with C-Suite Hires
-
Makor Capital Hires Lionel Botbol As Global Head Of Makor Investment Banking Division
-
Westwater Resources Announces Year-end 2020 Results and Business Update
-
Tilray (TLRY) PT Raised to $30.25 at Cantor Fitzgerald; 'Prefer to Play Merger Via APHA'
-
4D Pharma to Participate in Upcoming Cantor Fitzgerald Microbiome Leaders Panel
-
Companies with NDRs 2/16
-
Galmed Pharmaceuticals (GLMD) Announces Proposed Offering of Ordinary Shares
-
Galmed Pharmaceuticals Announces Proposed Offering of Ordinary Shares
-
Synlogic to Present at Upcoming Virtual Banking and Industry Conferences
-
CF Acquisition Corp. IV Announces Separate Trading of Class A Common Stock and Warrants
-
CF Acquisition Corp. IV Announces Separate Trading of Class A Common Stock and Warrants
-
NexImmune (NEXI) IPO Opens 35% Higher
-
VolitionRx Limited Announces Closing of $20 Million Underwritten Public Offering of Common Stock
-
Sanara MedTech (SMTI) Prices 1.1M Share Common Stock Offering at $25/Each
-
Sanara MedTech Inc. Announces Pricing of Public Offering
-
Corvus Pharma (CRVS) Announces Pricing of Public Offering of Common Stock
-
Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
HilltopSecurities Welcomes Brian Branigan to Fixed Income Capital Markets
-
MoneyLion to Become Publicly Traded via Merger with Fusion Acquisition Corp. (FUSE)
-
MoneyLion, America’s Leading Digital Financial Platform, to Become Publicly Traded via Merger with Fusion Acquisition Corp. (NYSE: FUSE)
-
Aurora Cannabis (ACB:CN) (ACB) PT Raised to Cdn$18 at Cantor Fitzgerald
-
Cantor Fitzgerald Downgrades Amicus Therapeutics (FOLD) to Neutral
-
NexImmune Inc. (NEXI) Prices 6.471M Share IPO at $17/Sh
-
NexImmune Announces Pricing of Upsized Initial Public Offering
-
NexImmune Announces Pricing of Upsized Initial Public Offering
-
Pivotal Investment Corp. III Announces Closing of $276,000,000 Initial Public Offering
-
Crown PropTech Acquisitions Announces Closing of $276 Million Initial Public Offering Including Full Exercise by Underwriters to Purchase Additional Shares

